Immunomodulatory, Inflammatory, and Vasoregulatory Properties of Transfused Red Blood Cell Units as a Function of Preparation and Storage (R01)

The summary for the Immunomodulatory, Inflammatory, and Vasoregulatory Properties of Transfused Red Blood Cell Units as a Function of Preparation and Storage (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Immunomodulatory, Inflammatory, and Vasoregulatory Properties of Transfused Red Blood Cell Units as a Function of Preparation and Storage (R01): -Purpose. The goal of this Funding Opportunity Announcement (FOA) in blood banking and transfusion medicine is to solicit novel basic and translational research projects which will identify the molecular and cellular changes that occur during red blood cell unit preparation and storage; and evaluate the immunomodulatory, inflammatory, and vasoactive effects of storage lesion elements from red blood cell units on the blood vessel wall, host cells, and tissue oxygenation. Only research applications involving human red blood cell units (and their components) suitable for transfusion in the U.S. and that are collected and stored according to methods approved by the U.S. FDA will be considered responsive to this FOA. Applications are encouraged that propose collaborations between investigators from different disciplines such as hematology, blood banking, transfusion medicine, immunology, cell biology, rheology, nanotechnologies, molecular biology, and other relevant disciplines. This program will promote interactions and resource sharing among the award recipients to maximize their research efforts. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. NHLBI intends to commit up to a total of $3.5 million in FY2009 to support an estimated 5 to 8 meritorious projects that are responsive to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Federal Grant Title:	Immunomodulatory, Inflammatory, and Vasoregulatory Properties of Transfused Red Blood Cell Units as a Function of Preparation and Storage (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-08-005
Type of Funding:	Grant
CFDA Numbers:	93.839
CFDA Descriptions:	Blood Diseases and Resources Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Jan 21, 2009
Posted Date:	Mar 21, 2008
Creation Date:	Mar 21, 2008
Archive Date:	Feb 21, 2009
Total Program Funding:	$3,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: For profit organizations other than small businesses County governments Native American tribal governments (Federally recognized) Independent school districts City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Public and State controlled institutions of higher education Special district governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Small businesses
Additional Information on Eligibility: Foreign institutions are not eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immu...; • New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional); • Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (...; • Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional); • Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional); • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders; • Clinical Hematology Research Career Development Program (K12); • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
More Grants from the National Institutes of Health: • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...; • Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Agi...